Invesco India Pharma and Healthcare Fund
- NAV
- ₹9.66
- —30 Oct 2026
- AUM (₹ Cr)
- 111
- Average, July - September 2026
- Expense ratio
- 3.30%
- Regular 5.19%
- Risk
- Very High
- SEBI riskometer
- 1Y return
- —
- Category 14.5%
- 3Y CAGR
- —
- Category 22.4%
- 5Y CAGR
- —
- Category 16.1%
Rank in category
Not ranked yet: a rank needs a year of returns.
Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily NAVs. Risk-free rate 6.5% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.7% | — | — | — | — | — | — | — | -3.6% |
| BSE Healthcare TRI | — | — | — | — | — | — | — | — | — |
| Healthcare average | -0.3% | -0.9% | 13.5% | 16.7% | 14.5% | 22.4% | 16.1% | 14.7% | 16.3% |
| Difference | — | — | — | — | — | — | — | — | — |
Portfolio
Valuation
- P/E of its shares
- 64.6
- Shares are 87% of the fund
- Category median
- 48.4
- 19 Healthcare funds
- Benchmark P/E
- 44.3
- BSE Healthcare
P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 17 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.
Fund details
- Fund house
- Invesco Mutual Fund
- Category
- Equity · Healthcare
- SEBI classification
- Equity / Sectoral
- Benchmark
- BSE Healthcare TRI
- Launch date
- 10 Sept 2026 (0.1 years)
- Structure
- Open Ended
- Plans and options
- Direct Growth, Regular Growth
- Fund manager
- Aditya Khemani
- Minimum SIP
- ₹100
- Minimum lumpsum
- ₹1,000 (then ₹1,000)
- Exit load
- 0.50%
- Lock-in
- None
- Riskometer
- Very High (benchmark Very High)
- Expense ratio as of
- 29 Oct 2026
- AUM period
- July - September 2026
- ISIN, Direct Growth
- INF205KA1BX5
- ISIN, Regular Growth
- INF205KA1BU1
- Scheme code
- 154547, 154545
NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.
Other healthcare funds
Other funds in the Healthcare category.
- LIC MF Healthcare FundLIC Mutual Fund · ₹99 Cr · ER 1.38%
- Nippon India Pharma FundNippon India Mutual Fund · ₹9,272 Cr · ER 0.99%5Y 14.2%
- ICICI Prudential Healthcare FundICICI Prudential Mutual Fund · ₹6,830 Cr · ER 1.30%5Y 16.7%
- SBI Healthcare Opportunities FundSBI Mutual Fund · ₹5,565 Cr · ER 1.00%5Y 19.2%
- DSP Healthcare FundDSP Mutual Fund · ₹3,721 Cr · ER 0.75%5Y 16.2%
- Mirae Asset Healthcare FundMirae Asset Mutual Fund · ₹3,458 Cr · ER 0.62%5Y 16.6%